How e-cigarette rules affect youth smoking and vaping
Official title: Evaluating the Effect of E-cigarette Policies on Youth Tobacco Use
Funded at University of Missouri-Columbia · NIH-11357625 · Data updated 2026-11-12
This grant studies how laws about e-cigarettes—like flavor bans, age limits, and taxes—affect how many youths and young adults use vaping and traditional tobacco products.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | June 1, 2018 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $514,213 |
| NIH project number | 5R01DA045016-10 |
| Project ID | NIH-11357625 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adolescents and young adults (including ages 20–21 and older) who are or could be affected by tobacco- and e-cigarette-related policies.
✕Less likely to help
Young people with no exposure to or interest in tobacco policies may not experience direct benefits.
What this research studies
This project uses real-world data from large youth health surveys to see whether flavor bans, Tobacco 21 policies, and new e-cigarette taxes change youth vaping and cigarette use. It applies quasi-experimental methods to compare trends before and after policy changes across different states and times. The goal is to understand which policies reduce youth use and whether some policies shift teens toward other tobacco products. The research relies on high-quality datasets to provide timely insights for policymakers and the public.
Why it matters
Potential benefit: If successful, findings could guide more effective youth tobacco policies and reduce future nicotine use among young people.
How similar studies have gone: Previous policy-evaluation work using large surveys and quasi-experimental designs has shown that policies can influence youth tobacco use, supporting potential impact for this approach.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Pesko, Michael — University of Missouri-Columbia
- Study coordinator: Pesko, Michael
Related research
Other NIH-funded projects on the same topics.
-
Ending Tobacco Use with a Smartphone Program for Cambodian People Living with HIV/AIDS
A smartphone-based quit-smoking program designed for people living with HIV/AIDS in Cambodia to help reduce tobacco use alongside HIV treatment.
-
Optimizing lung cancer care with smart tools for prevention, early detection, treatment, and survivorship
A U01 grant using AI and biomarkers to improve lung cancer prevention, screening, treatment, and survivorship care for people at risk or living with lung cancer.
-
How deforestation affects alcohol and tobacco use in Indonesia
This project looks at whether forest loss in Indonesia is linked to changes in people's tobacco and alcohol use across different places and years.
-
Dynamic patterns of oral nicotine pouch use and tobacco transitions in adults
A long-term study is following adults to understand how people start, switch, or stop using oral nicotine pouches, cigarettes, and other tobacco products.
-
Modeling how tobacco rules affect real people in the US
A project uses computer models to estimate how flavor bans and other tobacco policies might change smoking and related health outcomes for different groups of people.
-
Phone text program to help people with HIV in Uganda and Zambia stop smoking
This program uses tailored text messages and nicotine patches to help people living with HIV in Uganda and Zambia quit tobacco.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.